Rifaximin (Xifaxan 550) for hepatic encephalopathy.
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016527:Drug Costs; D006501:Hepatic Encephalopathy / Q000188:drug therapy*; D006801:Humans; D012008:Recurrence; D012294:Rifamycins / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000078262:Rifaximin; D013607:Tablets; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D012294:Rifamycins; D013607:Tablets; D000078262:Rifaximin